SwitchGear Genomics announces distribution agreement for FuGENE® HD transfection reagent and novel transfection optimization kit

January 19th, 2011 SwitchGear is pleased to offer for direct sale FuGENE HD transfection reagent along with proprietary transfection optimization kit MENLO PARK, Calif. – January 19, 2011 – SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced that the company will offer FuGENE® HD transfection reagent as an individual product and as part of its novel LightSwitch Transfection Optimization Kit. SwitchGear has also recently launched the innovative LightSwitch Luciferase Assay System™, a full reporter assay solution including a genome-wide collection of assay-ready GoClone™ human promoter and 3’UTR luciferase reporters and optimized luciferase assay reagents for measuring transcriptional activation and translational efficiency in living cells. The company is also offering FuGENE® HD transfection reagent to complement the product line. “As a part of SwitchGear’s commitment to providing a complete reporter assay solution, we offer an start-to-finish system that will allow researchers to perform reporter assays quickly and easily without having to do any cloning or reagent optimization,” said Patrick Collins, Ph.D., Director of Research and Development. SwitchGear has also developed the novel LightSwitch Transfection Optimization Kit utilizing FuGENE® HD. The kit contains everything required to optimize transfection conditions for any cell line and condition of interest. SwitchGear announced a new program entitled “The Transfection Optimization Challenge” where the company has openly invited researchers to use the kit to both optimize their own experiments and receive free GoClone products. Visit http://switchgeargenomics.com/transfection-optimization-challenge/ to learn how to participate in the “Transfection Optimization Challenge.” About SwitchGear Genomics, Inc.: SwitchGear Genomics Inc. is a leading provider of technologically innovative products for studying the regulatory elements in the human genome. The company has developed a comprehensive approach to generate new insights into gene regulatory network, allowing researchers to efficiently screen entire pathways in living cells. SwitchGear was founded in March 2005 by Dr. Richard Myers, Dr. Nathan Trinklein and Dr. Shelley Force Aldred from Stanford University. For more information about SwitchGear, please visit the company’s website at www.switchgeargenomics.com Contact info: Nathan Trinklein, Ph.D. CEO and co-founder of SwitchGear Genomics 650-323-6763